News and Articles
SABM Research Initiatives
Type: News
Date Posted: Thursday, July 21st, 2005
The Society for the Advancement of Blood Management has made great progress toward developing educational and research initiatives that further our mission: To improve patient outcomes through optimal blood management, which includes the appropriate provision and use of blood and blood products; and strategies to reduce or avoid transfusion. Two examples of such initiatives were summarized in the Spring Newsletter and have been posted on the Members Only section of SABM’s website (www.sabm.org/members).
The Development of an Evidence-Based Consensus on the use of Recombinant Human Factor VIIa Therapy
Under the leadership of Aryeh Shander, MD, FCCM, FCCP, Chief, Department of Anesthesiology and Critical Care Medicine, Englewood Hospital and Medical Center and Clinical Professor of Anesthesiology and Medicine, Mount Sinai School of Medicine, a consensus development conference on the use of recombinant factor VIIa (rVIIa) in non-approved clinical settings was convened July 16-18, 2004. This conference was co-sponsored by SABM and the University HealthSystem Consortium (UHC), and co-directed by Robert Dubois, MD, PhD, Associate Professor of Medicine, UCLA and Karl Matuszewski, MS, PharmD, Co-Chair, Senior Director, Clinical Knowledge Services University HealthSystem Consortium. A multi-disciplinary panel of experts, utilizing a modified Rand methodology and structured literature search and review, developed consensus recommendations for the rise of rVIIa in non-approved settings (www.sabm.org/members/research).
Erythropoiesis Forum: Evaluation and Management of the Elective Surgical Patient
A second initiative was a conference to develop a clinical care pathway for the detection, evaluation and management of anemia in the elective surgery patient. SABM has identified this as an unmet medical need and sponsored a multi-disciplinary panel to develop such a pathway (www.sabm.org/members/research).
We would like to invite you to visit the SABM website to read more about these research initiatives. As a member, you benefit from being able to view the recommendations of these panels before they are made available to the general medical community. You will need your username and password to access this information. If you don’t know your username and password please send an e-mail to the SABM office at info@sabm.org.
n
Web site: http://www.sabm.org/members/research
Email: info@sabm.org
The Development of an Evidence-Based Consensus on the use of Recombinant Human Factor VIIa Therapy
Under the leadership of Aryeh Shander, MD, FCCM, FCCP, Chief, Department of Anesthesiology and Critical Care Medicine, Englewood Hospital and Medical Center and Clinical Professor of Anesthesiology and Medicine, Mount Sinai School of Medicine, a consensus development conference on the use of recombinant factor VIIa (rVIIa) in non-approved clinical settings was convened July 16-18, 2004. This conference was co-sponsored by SABM and the University HealthSystem Consortium (UHC), and co-directed by Robert Dubois, MD, PhD, Associate Professor of Medicine, UCLA and Karl Matuszewski, MS, PharmD, Co-Chair, Senior Director, Clinical Knowledge Services University HealthSystem Consortium. A multi-disciplinary panel of experts, utilizing a modified Rand methodology and structured literature search and review, developed consensus recommendations for the rise of rVIIa in non-approved settings (www.sabm.org/members/research).
Erythropoiesis Forum: Evaluation and Management of the Elective Surgical Patient
A second initiative was a conference to develop a clinical care pathway for the detection, evaluation and management of anemia in the elective surgery patient. SABM has identified this as an unmet medical need and sponsored a multi-disciplinary panel to develop such a pathway (www.sabm.org/members/research).
We would like to invite you to visit the SABM website to read more about these research initiatives. As a member, you benefit from being able to view the recommendations of these panels before they are made available to the general medical community. You will need your username and password to access this information. If you don’t know your username and password please send an e-mail to the SABM office at info@sabm.org.
n